الكليات

Abdul Razak Kasmuri
Associate Professor
- KULLIYYAH OF PHARMACY
- IIUM Kuantan Campus
- drazak@iium.edu.my
- 4871
Staff Detail
Abdul Razak Bin Kasmuri obtained his MD and MSc (Pharmacology) degrees from School of Medical Sciences USM and PhD degree from School of Pharmaceutical Sciences USM Penang. Upon completion of his PhD he joined Kulliyyah of Pharmacy, IIUM. He was a Deputy Dean of Postgraduate and Research in 2006/2007 and Deputy Dean of Student Affairs in 2008/2009 at Kulliyyah pharmacy. He chaired a committee in drafting the IIUM Animal Ethics Policy in 2009 and the policy was endorsed by university senate in 2012. He was a committee member of Malaysian Society of Pharmacology and Physiology (MSPP) for 2007/2 ... show more
- PhD in Pharmacalogy (Drug Development) - Doctor of Philosophy, Universiti Sains Malaysia (USM)
- Master of Science (Pharmacology) - Masters Degree, Universiti Sains Malaysia (USM)
- Doctor of Medicine - Bachelor Degree, Universiti Sains Malaysia (USM)
- Natural Science ~ Mathematical Sciences ~ Mathematics and Statistics for Science and Engineering ~ Biological and Medical Sciences - Utilizing diabetic animal models in studying effect of antidiabetics herbs
- Biotechnology ~ Biotechnology ~ Animal Biotechnology ~ Cell Line Culture - Utilizing cell line in screening antidiabetics herbs
- Medical And Health ~ Medical And Health Sciences ~ Pharmacology ~ Clinical Pharmacology - Study the mode of action of medicinal herbs
- Medical And Health ~ Medical And Health Sciences ~ Pharmacology ~ Other Pharmacology n.e.c. - Development of pharmacological models in screening antidiabetics herbs.
- Medical And Health ~ Medical And Health Sciences ~ Pharmacy ~ Drug Discovery - Characterization and separation of active compounds of screened antidiabetic herbs
ANTI CANCER CHEMOTHERAPY | 2012/2013 2013/2014 2014/2015 2015/2016 2017/2018 2018/2019 2019/2020 2020/2021 |
ANTI-INFECTIVE & CYTOTOXIC AGENTS | 2009/2010 2010/2011 2011/2012 2012/2013 2013/2014 |
ANTI-INFECTIVE AGENTS | 2020/2021 |
ANTI-INFECTIVES AGENTS | 2011/2012 2012/2013 2013/2014 2014/2015 2016/2017 2017/2018 2018/2019 2020/2021 |
Antiinfective and Cytotoxic Agents | 2008/2009 |
BODY SYSTEM I : CARDIOVACULAR & HAEMATOLOGY | 2012/2013 2013/2014 2014/2015 2016/2017 2017/2018 2018/2019 2019/2020 |
BODY SYSTEM II : RESPIRATORY & URINARY SYSTEM | 2016/2017 2017/2018 2018/2019 2019/2020 |
BODY SYSTEM III : MUSCULOSKELETAL & SENSORY ORGANS | 2011/2012 2012/2013 2013/2014 2014/2015 2016/2017 2017/2018 2019/2020 |
BODY SYSTEM IV: GASTROINTESTINAL &HEPATOBILIARY SYSTEMS | 2017/2018 2018/2019 2019/2020 2020/2021 |
BODY SYSTEM V : ENDOCRINE & REPRODUCTIVE SYSTEMS | 2012/2013 2013/2014 2014/2015 2015/2016 2017/2018 2018/2019 2019/2020 2020/2021 |
BODY SYSTEM VI : CNS | 2012/2013 2013/2014 2014/2015 2016/2017 2017/2018 2018/2019 2019/2020 |
BODY SYSTEM VII : CENTRAL NERVOUS SYSTEM | 2009/2010 2010/2011 2011/2012 |
BODY SYSTEM VIII : SENSORY ORGAN | 2009/2010 2010/2011 2011/2012 2012/2013 2013/2014 |
Body System IV : Musculo-skeletal | 2010/2011 2011/2012 |
Body System VIII : Sensory Organs | 2006/2007 2007/2008 2008/2009 |
CLINICAL TOXICOLOGY | 2020/2021 |
Clinical Pharmacy II | 2009/2010 |
Clinical Toxicology | 2012/2013 2013/2014 2014/2015 2015/2016 2016/2017 2018/2019 2019/2020 |
Drug Delivery System | 2010/2011 |
FAMILY MANAGEMENT AND PARENTING | 2012/2013 2013/2014 2014/2015 2015/2016 2016/2017 2017/2018 2018/2019 2019/2020 |
FUNDAMENTALS OF PHARMACOLOGY | 2012/2013 2013/2014 2015/2016 2016/2017 2017/2018 |
FUNDAMENTALS OF PHYSIOLOGY | 2010/2011 2011/2012 2012/2013 2013/2014 |
Fundamentals of Pharmacology | 2010/2011 2011/2012 |
HALAQAH 1 | 2007/2008 |
HALAQAH 2 | 2006/2007 2007/2008 |
ISLAMIC INPUT IN PHARMACY | 2010/2011 2011/2012 2012/2013 2013/2014 2015/2016 2016/2017 2017/2018 |
OTC (over the counter) Medication | 2011/2012 |
PHARMACOLOGY OF PERIPHERAL NERVOUS SYSTEM | 2020/2021 |
PHARMACOLOGY OF THE PERIPHERAL NERVOUS SYSTEM | 2010/2011 2011/2012 2012/2013 2013/2014 2014/2015 2015/2016 2016/2017 2017/2018 2018/2019 |
Pharmacokinetics and Biopharmaceutics | 2006/2007 2007/2008 |
Pharmacotherapeutics II | 2009/2010 |
Problem-based Learning I | 2006/2007 |
Problem-based Learning II | 2006/2007 |
STUDY CIRCLE 1 | 2011/2012 |
STUDY CIRCLE 2 | 2010/2011 2011/2012 |
STUDY CIRCLE 2 (BROTHER) | 2012/2013 2013/2014 |
Completed |
|
---|---|
2016 - 2019 | Influence of multiple reaction monitoring (MRM) on the separation of amlodipine and perindopril in pharmaceutical dosage form and plasma |
2016 - 2018 | ??Glucosidase Inhibitor and Aroma from the Flesh of Salak (Salacca zalacca) Fruit, their Metabolic Demarcation and Antidiabetic Potential |
2016 - 2019 | Incorporation of stingless bee honey into hydrogel as a potential wound healing promoter |
2016 - 2018 | ??Glucosidase Inhibitor and Aroma from the Flesh of Salak (Salacca zalacca) Fruit, their Metabolic Demarcation and Antidiabetic Potential |
2016 - 2018 | ??Glucosidase Inhibitor and Aroma from the Flesh of Salak (Salacca zalacca) Fruit, their Metabolic Demarcation and Antidiabetic Potential |
2015 - 2020 | Addressing Formulation Issues of Syariah Compliant Generic Sustained Release Antidiabetic Solid Dosage Form |
2015 - 2019 | The Effects of the Antioxidant Active Fractions of Ficus Deltoidea on Fatty Acid Induced-Insulin Resistance Cells Model as a Potential Therapeutic Agent for Types 2 Diabetes Mellitus |
2015 - 2019 | Isolation Of ?-Glucosidase Inhibitor and aroma from the Flesh of Salak (Salacca zalacca) Fruit and Their Metabolic Profiling on GC/MS. |
2014 - 2017 | Estimation of Amlodipne Level in Diabetic and Hypertensive Rats' Urine and its Effects on Adrenergic Receptors |
2014 - 2018 | Synthesis and Mechanistic Evaluation of Orvinol Analogues as Potential Anti-Relapse to Morphine/ Methamphetamine Dependence |
2014 - 2018 | In Vitro Anticancer Potentials Of Ethyl P-Methoxycinnamate (EPMC) An Active Ingredient Of Cekur (Kaempferia Galanga) On Human Cancer Cell Lines Differing In P53 Status. |
2013 - 2018 | Nano-Transfersomes as a Novel Elastic Transdermal Carrier to Address Poor Bioavailability Issue of Raloxifene Hydrochloride |
2012 - 2013 | Effects of Pluchea Indica on Glucose Uptake and Glucose Transportation (Glut 4) Gene Expression of Adipocyte Cells |
2012 - 2015 | Sintesis analog dan modifikasi struktur mitragynine untuk mengkaji perkaitan di antara stuktur mitragynine dengan kesan psikoaktif drug |
2012 - -1 | Effects of Pluchea Indica on Glucose Uptake and Glucose Transportation (Glut 4) Gene Expression of Adipocyte Cells |
2011 - 2014 | Bio-equivalence Study of Generic Gliclazide Tablet (IIUM Pharmacy) and Brand-name Gliclazide Tablet (Diamicron)in Healthy Male Volunteers |
2010 - 2016 | Structure-Based Virtual Screening of Chemical Libraries and Functional Assay on Small-Cell Lung Cancer In Vivo Molecular Targets |
2010 - 2013 | Bioactivity-guided fractionation of Pluchea Indica (beluntas) extract by using RIN5f pancreatic ?-cell line |
2007 - 2010 | Study on Antidiabetic Effect and the Possible Mechanism of Action of Pithecellobium Jiringa (Jering) |
2006 - 2008 | Nanoemulsion of Palm Olein for Drug Delivery |
In Progress |
|
2016 - Present | ??Glucosidase Inhibitor and Aroma from the Flesh of Salak (Salacca zalacca) Fruit, their Metabolic Demarcation and Antidiabetic Potential |
2016 - Present | Incorporation of stingless bee honey into hydrogel as a potential wound healing promoter |
2016 - Present | Influence of multiple reaction monitoring (MRM) on the separation of amlodipine and perindopril in pharmaceutical dosage form and plasma |
2015 - Present | Addressing Formulation Issues of Syariah Compliant Generic Sustained Release Antidiabetic Solid Dosage Form |